At the news
? NEUTRALIMPACT 2/10 144 filed Oct 22, 2026 at 16:03 ET
Elevance Health officer Mark Kaye filed a Form 144 notice of intent to sell 10,584 shares of common stock, with an estimated aggregate market value of approximately $4.66 million based on the filing date. The shares were acquired through restricted stock and performance share grants between October 2022 and October 2026. This is a routine insider sale notice and does not indicate a change in company fundamentals.
- Officer Mark Kaye filed Form 144 to sell 10,584 shares of Elevance Health common stock.
- Estimated aggregate market value of the proposed sale is approximately $4.66 million.
- Shares were acquired through restricted stock and performance share grants from October 2022 through October 2026.
- The sale is planned to occur on or after October 22, 2026, on the NYSE.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access